Come up with a name for your new list and we'll add to it:
Invizius raised a round of funding on May 02, 2018. Investors include
Mercia Fund Managers.
Invizius is advaincing a solution to reduce the risk of cardiovascular disease among patients undergoing long-term dialysis. Its H-Guard product is an anti-inflammatory used as a 'primer' to coat the …